Posted by Michael Wonder on 30 Jan 2016
First specific replacement therapy to treat rare bleeding disorder
29 January 2016 - Coagadex recommended for approval for prevention of bleeding episodes for patients with factor X deficiency.
For more details, go to: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/01/news_detail_002462.jsp&mid=WC0b01ac058004d5c1
